Get the Stockscreener App
3.59
4.66%
0.16
After Hours:
3.60
0.01
+0.28%
Agilon Health Inc Stock (AGL) Latest News
agilon health, inc. (NYSE:AGL) Stake Boosted by Inspire Investing LLC - MarketBeat
Is agilon health, inc. (AGL) the Hottest Smid-Cap Stock So Far In 2025? - Insider Monkey
agilon health validates InvestingPro's Fair Value analysis with 60% rally - MSN
agilon health validates InvestingPro's Fair Value analysis with 60% rally By Investing.com - Investing.com Canada
Analysts Set agilon health, inc. (NYSE:AGL) PT at $4.03 - MarketBeat
agilon health (NYSE:AGL) Trading 8.5% Higher on Analyst Upgrade - MarketBeat
agilon health, inc. (NYSE:AGL) Stake Boosted by JPMorgan Chase & Co. - MarketBeat
Here’s Why Analysts Just Upgraded Agilon Health (AGL) - MSN
Market-Perform maintained for agilon health stock amid cash flow prudence - Investing.com India
Sanford C. Bernstein Increases agilon health (NYSE:AGL) Price Target to $3.15 - MarketBeat
Further Upside For agilon health, inc. (NYSE:AGL) Shares Could Introduce Price Risks After 29% Bounce - Simply Wall St
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies - Investing.com Australia
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Trading Up 6.4%Time to Buy? - MarketBeat
Citigroup Upgrades agilon health (AGL) - MSN
Commit To Buy Agilon Health At $2, Earn 37.5% Using Options - Nasdaq
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective - Investing.com India
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Earns Hold Rating from Analysts at Needham & Company LLC - MarketBeat
agilon health (NYSE:AGL) Shares Up 9.6%Here's What Happened - MarketBeat
Securities Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against agilon health, inc. - AccessWire
Short Interest in agilon health, inc. (NYSE:AGL) Declines By 6.7% - MarketBeat
agilon health, inc. (NYSE:AGL) Position Cut by Stifel Financial Corp - Defense World
Agilon Health, Inc, B. Riley Financial, Target Corporation, - GlobeNewswire
Agilon Health, Inc, B. Riley Financial, Target Corporation, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
agilon health, inc. (NYSE:AGL) Receives $4.28 Consensus Target Price from Analysts - MarketBeat
agilon health (NYSE:AGL) Trading Down 5.8%Here's Why - MarketBeat
agilon health Slides As Insider Purchases Lose Another US$50k - Simply Wall St
agilon health (NYSE:AGL) Trading 5% HigherWhat's Next? - MarketBeat
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc.AGL - The Eastern Progress Online
agilon health (NYSE:AGL) Stock Price Down 7.8%Here's Why - MarketBeat
Forecasting The Future: 10 Analyst Projections For Agilon Health - Benzinga
agilon health, inc. (NYSE:AGL) Short Interest Update - MarketBeat
agilon health (NYSE:AGL) Now Covered by Analysts at Macquarie - MarketBeat
Macquarie starts agilon health at Neutral amid market challenges - Investing.com
Macquarie starts agilon health at Neutral amid market challenges By Investing.com - Investing.com South Africa
Agilon Health's SWOT analysis: stock faces challenges amid value-based care push - Investing.com
agilon health, inc. (NYSE:AGL) Director Purchases $55,000.00 in Stock - MarketBeat
Agilon Health director McLoughlin buys $55,084 in stock By Investing.com - Investing.com Canada
Agilon Health director McLoughlin buys $55,084 in stock - Investing.com India
Agilon Health director Silvana Battaglia acquires $50,269 in stock By Investing.com - Investing.com Australia
Agilon Health director Silvana Battaglia acquires $50,269 in stock - Investing.com
3.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):